Literature DB >> 1379084

Type beta transforming growth factors promote interleukin-3 (IL-3)-dependent differentiation of human basophils but inhibit IL-3-dependent differentiation of human eosinophils.

C Sillaber1, K Geissler, R Scherrer, R Kaltenbrunner, P Bettelheim, K Lechner, P Valent.   

Abstract

Basophils and eosinophils share a common differentiation pathway. Factors regulating terminal commitment toward one cell type, however, have so far not been defined. Interleukin-3 (IL-3) is a potent differentiation factor for both human eosinophils and basophils. In the present study, the effects of various recombinant human (rh) growth regulators on IL-3-dependent growth of eosinophils and basophils were studied in a bone marrow (BM) suspension culture system (normal donors, n = 13). We found that type beta transforming growth factors (TGFs) lead to a significant increase in the absolute numbers of basophils in BM cultures grown in the presence of IL-3 (day 14 of culture; IL-3: 133 +/- 20 v IL-3 + TGF-beta 1: 231 +/- 28 x 10(3)/mL [P less than .01]) and to an increase in the total histamine values (IL-3: 72.6 +/- 22.2 v IL-3 + TGF-beta 1: 142.9 +/- 37.3 ng/mL [P less than .015]) compared with rhIL-3 alone. In contrast, type beta TGFs were found to inhibit the IL-3-dependent growth of eosinophils (IL-3: 170.4 +/- 37.2 v IL-3 + TGF-beta 1: 16.7 +/- 5.2 x 10(3)/mL [P less than .01]) and formation of eosinophil cationic protein in the same culture system. The effect of TGF-beta 1 (and TGF-beta 2) on IL-3-dependent differentiation of basophils and eosinophils was dose- and time-dependent (maximum effects observed with 1 to 10 ng/mL of rhTGF-beta 1 or TGF-beta 2) and could be neutralized by an antibody specific for TGF-beta 1. In contrast to the TGFs, interferon-alpha (IFN-alpha) and IFN-gamma were found to downregulate IL-3-dependent formation of both basophils (IL-3: 167 +/- 33 v IL-3 + IFN-alpha: 67 +/- 25 v IL-3 + IFN-gamma: 65 +/- 33 x 10(3)/mL [P less than .01]) and eosinophils (IL-3: 239 +/- 5 v IL-3 + IFN-alpha: 81 +/- 4 v IL-3 + IFN-gamma: 67 +/- 17 x 10(3)/mL [P less than .05]) in our culture system. Type beta TGFs as well as the IFNs failed to directly induce differentiation of human basophils or eosinophils in the absence of other growth factors. Together, these results show that type beta TGFs and IFNs are potent regulators of cytokine-dependent growth and differentiation of human allergic effector cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379084

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.

Authors:  Peter Valent; Gerald J Gleich; Andreas Reiter; Florence Roufosse; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Karl Sotlar; Joseph H Butterfield; Sabine Cerny-Reiterer; Matthias Mayerhofer; Peter Vandenberghe; Torsten Haferlach; Bruce S Bochner; Jason Gotlib; Hans-Peter Horny; Hans-Uwe Simon; Amy D Klion
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

Review 2.  Proposed diagnostic criteria and classification of basophilic leukemias and related disorders.

Authors:  P Valent; K Sotlar; K Blatt; K Hartmann; A Reiter; I Sadovnik; W R Sperr; P Bettelheim; C Akin; K Bauer; T I George; E Hadzijusufovic; D Wolf; J Gotlib; F-X Mahon; D D Metcalfe; H-P Horny; M Arock
Journal:  Leukemia       Date:  2017-01-16       Impact factor: 11.528

Review 3.  Eosinophils: multifaceted biological properties and roles in health and disease.

Authors:  Hirohito Kita
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

4.  Effect of IL-4 and interferon-gamma (IFN-gamma) on IL-3- and IL-5-induced eosinophil differentiation from human cord blood mononuclear cells.

Authors:  K Ochiai; I Iwamoto; H Takahashi; S Yoshida; H Tomioka; S Yoshida
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

Review 5.  Diagnosis and treatment of eosinophilic myocarditis.

Authors:  Zezhong Zhong; Zicong Yang; Yiming Peng; Lei Wang; Xuming Yuan
Journal:  J Transl Autoimmun       Date:  2021-09-02

Review 6.  Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.

Authors:  Peter Valent; Lina Degenfeld-Schonburg; Irina Sadovnik; Hans-Peter Horny; Michel Arock; Hans-Uwe Simon; Andreas Reiter; Bruce S Bochner
Journal:  Semin Immunopathol       Date:  2021-05-30       Impact factor: 9.623

7.  Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis.

Authors:  R Alam; P Forsythe; S Stafford; Y Fukuda
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

8.  Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites.

Authors:  F D Finkelman; K B Madden; A W Cheever; I M Katona; S C Morris; M K Gately; B R Hubbard; W C Gause; J F Urban
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

Review 9.  The underestimated role of basophils in Ph+ chronic myeloid leukaemia.

Authors:  Peter Valent; Hans-Peter Horny; Michel Arock
Journal:  Eur J Clin Invest       Date:  2018-08-06       Impact factor: 4.686

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.